FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Simmons

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Concepts & Ideas

Procedures

Patch-Clamp Techniques

Genes & Molecular Sequences

Amino Acid Sequences

Co-author Network

Publications

TOP 3
Mark A Simmons; Jennifer L Werkheiser; thomas john hudzik
Acute nicotine and phencyclidine increase locomotor activity of the guinea pig with attenuated potencies relative to their effects on rat or mouse.
Mark A Simmons; C D Sobotka-Briner; A M Medd
Localization and function of NK(3) subtype tachykinin receptors of layer V pyramidal neurons of the guinea-pig medial prefrontal cortex.
Debbie J Beard; Shane Alan Perrine; Everet Phillips; Sarah Hoque; Sarah Conerly; Carolyn Tichenor; Mark A Simmons; John K Young
Conformational comparisons of a series of tachykinin peptide analogs.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Simmons (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Mark A Simmons; Jennifer L Werkheiser; thomas john hudzik
Acute nicotine and phencyclidine increase locomotor activity of the guinea pig with attenuated potencies relative to their effects on rat or mouse.
Pharmacology, biochemistry, and behavior 2010;94(3):410-5.
2008: Mark A Simmons; C D Sobotka-Briner; A M Medd
Localization and function of NK(3) subtype tachykinin receptors of layer V pyramidal neurons of the guinea-pig medial prefrontal cortex.
Neuroscience 2008;156(4):987-94.
2007: Debbie J Beard; Shane Alan Perrine; Everet Phillips; Sarah Hoque; Sarah Conerly; Carolyn Tichenor; Mark A Simmons; John K Young
Conformational comparisons of a series of tachykinin peptide analogs.
Journal of medicinal chemistry 2007;50(26):6501-6.
2006: Mark A Simmons
Functional selectivity of NK1 receptor signaling: peptide agonists can preferentially produce receptor activation or desensitization.
The Journal of pharmacology and experimental therapeutics 2006;319(2):907-13.
2005: Mark A Simmons
Functional selectivity, ligand-directed trafficking, conformation-specific agonism: what's in a name?
Molecular interventions 2005;5(3):154-7.
2005: VJ Bennett; Shane Alan Perrine; Mark A Simmons
Neurokinin-1 receptor resensitization precedes receptor recycling.
The Journal of pharmacology and experimental therapeutics 2005;313(3):1347-54.
2003: Shane Alan Perrine; VJ Bennett; Mark A Simmons
Tachykinin peptide-induced activation and desensitization of neurokinin 1 receptors.
Peptides 2003;24(3):469-75.
2002: VJ Bennett; Shane Alan Perrine; Mark A Simmons
A novel mechanism of neurokinin-1 receptor resensitization.
The Journal of pharmacology and experimental therapeutics 2002;303(3):1155-62.
2001: Mark A Simmons
Changes of the responses of single sympathetic ganglionic neurones to substance P following desensitization.
Journal of autonomic pharmacology 2001;21(2):101-12.
2000: Shane Alan Perrine; Tracy Whitehead; Rickey P Hicks; John L Szarek; James E Krause; Mark A Simmons
Solution structures in SDS micelles and functional activity at the bullfrog substance P receptor of ranatachykinin peptides.
Journal of medicinal chemistry 2000;43(9):1741-53.
1998: Mark A Simmons; C R Schneider
Regulation of M-type potassium current by intracellular nucleotide phosphates.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1998;18(16):6254-60.
1997: Mark A Simmons; Robbin M Brodbeck; VV Karpitskiy; C R Schneider; David Neff; James E Krause
Molecular characterization and functional expression of a substance P receptor from the sympathetic ganglion of Rana catesbeiana.
Neuroscience 1997;79(4):1219-29.
1996: takayuki tokimasa; Mark A Simmons; C R Schneider; Takashi Akasu
Hyperpolarizing shift of the M-current activation curve after washout of muscarine in bullfrog sympathetic neurons.
Neuroscience letters 1996;207(2):97-100.
1995: takayuki tokimasa; M Ito; Mark A Simmons; C R Schneider; T Tanaka; T Nakano; Takashi Akasu
Inhibition by wortmannin of M-current in bullfrog sympathetic neurones.
British journal of pharmacology 1995;114(2):489-95.
1995: D J Bradshaw; Mark A Simmons
gamma-Aminobutyric acidA receptor function is modulated by cyclic GMP.
Brain research bulletin 1995;37(1):67-72.
1994: Mark A Simmons; C R Schneider; James E Krause
Regulation of the responses to gonadotropin-releasing hormone, muscarine and substance P in sympathetic neurons by changes in cellular constituents and intracellular application of peptide fragments of the substance P receptor.
The Journal of pharmacology and experimental therapeutics 1994;271(2):581-9.
1993: Takashi Akasu; M Ito; T Nakano; C R Schneider; Mark A Simmons; T Tanaka; takayuki tokimasa; M Yoshida
Myosin light chain kinase occurs in bullfrog sympathetic neurons and may modulate voltage-dependent potassium currents.
Neuron 1993;11(6):1133-45.
1993: Mark A Simmons; C R Schneider
Amyloid beta peptides act directly on single neurons.
Neuroscience letters 1993;150(2):133-6.
1992: Mark A Simmons; R J Mather
Intracellular guanosine-5'-O-(2-thiodiphosphate) alters the dynamics of receptor-mediated responses in bullfrog sympathetic neurons.
Molecular pharmacology 1992;41(3):527-34.
1991: Mark A Simmons; R J Mather
Selectivity of the effects of guanosine-5'-O-(2-thiodiphosphate) on agonist inhibition of the M-current in amphibian sympathetic neurons.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1991;11(7):2130-4.
1991: Alfredo Kirkwood; Mark A Simmons; R J Mather; John E Lisman
Muscarinic suppression of the M-current is mediated by a rise in internal Ca2+ concentration.
Neuron 1991;6(6):1009-14.
1990: Mark A Simmons; J B Becker; R J Mather
Desensitization of the inhibition of the M-current in sympathetic neurons: effects of ATP analogs, polyanions, and multiple agonist applications.
Neuron 1990;4(4):557-62.
1989: Mark A Simmons; Edwin Johnson; Jill B Becker; D G Todd; V E Reichenbecher; William D McCumbee; G L Wright
An endogenous 'hypertensive factor' enhances the voltage-dependent calcium current.
FEBS letters 1989;254(1-2):137-40.